Erlotinib Stada

Erlotinib Stada is an oral medication used to treat certain types of cancer. This targeted therapy works by inhibiting specific proteins involved in cancer cell growth.

Erlotinib Stada is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It targets the epidermal growth factor receptor (EGFR), which plays a role in cancer cell proliferation. Patients often wonder, 'What is Erlotinib used for?'—it is designed to slow or stop the growth of cancer cells that have specific mutations.

Common effects of Erlotinib Stada may include skin rash, diarrhea, and fatigue. Some users also experience appetite loss and nausea. These effects can vary in severity and may differ from person to person.

Erlotinib Stada should be handled with care, stored properly, and used as directed by a healthcare professional. It is important to follow safety guidelines to minimize potential risks. Always consult a healthcare provider before starting any new medication.

Erlotinib Stada may interact with certain medications, including those that affect liver enzymes. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances may also affect how this medication works.